SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk
13 references·0 citing·39 second hop
Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk (2013)Screening for Diabetes and Prediabetes Sh…Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving (2010)Screening Adults for Pre-Diab…Quality of Life and Cost-effectiveness of a 3-Year Trial of Lifestyle Intervention in Primary Health Care (2010)Quality of Life and Cost-effe…Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review (2010)Cost-Effectiveness of Interve…Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis (2010)Age at initiation and frequen…Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Costs of Diabetes in…Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Costs of Diabetes in…Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis (2008)Different strategies for scre…Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults (2007)Cost-Effectiveness of Screeni…Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis (2004)Screening for Type 2 Diabetes…Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes (2003)Within-Trial Cost-Effectivene…Economic Costs of Diabetes in the U.S. in 2002 (2003)Economic Costs of Diabetes in…Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program (2003)Costs Associated With the Pri…How should cost data in pragmatic randomised trials be analysed? (2000)How should cost data in pragm…Cost-Effectiveness in Health and Medicine (1996)A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation (2005)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? (2020)Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62) (2002)A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) (2004)The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial (2008)Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions (2011)Department of Labor (1941)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial (2012)Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications (2013)Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review (2020)Valuing Health-Related Quality of Life in Diabetes (2002)Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes (2005)Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States (2006)Value of Lifestyle Intervention to Prevent Diabetes and Sequelae (2014)Does Diversity Matter for Health? Experimental Evidence from Oakland (2019)How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study (2003)Global healthcare expenditure on diabetes for 2010 and 2030 (2010)Prevention effectiveness : a guide to decision analysis and economic evaluation (1996)Economic Consequences of Diabetes Mellitus in the U.S. in 1997 (1998)Ethnic Disparities in Diabetic Complications in an Insured Population (2002)Economic Costs of Diabetes in the U.S. in 2012 (2013)The State of US Health, 1990-2010 (2013)Social Determinants of Health and Diabetes: A Scientific Review (2020)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians (2007)Health Psychology: The Search for Pathways between Behavior and Health (2007)Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force (2015)Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure (2004)Economic Costs of Diabetes in the U.S. in 2017 (2018)Financial cost of social exclusion: follow up study of antisocial children into adulthood (2001)Improving the reporting of pragmatic trials: an extension of the CONSORT statement (2008)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)
this work references cited by second hop

References

  • 2003Economic Costs of Diabetes in the U.S. in 20024,147 cited
  • 2008Economic Costs of Diabetes in the U.S. in 20071,360 cited
  • 2008Economic Costs of Diabetes in the U.S. in 2007781 cited
  • 2000How should cost data in pragmatic randomised trials be analysed?771 cited
  • 2010Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review491 cited
  • 2003Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program358 cited
  • 2008Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis290 cited
  • 2010Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis286 cited
  • 2003Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes262 cited
  • 2004Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis178 cited
  • 2007Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults111 cited
  • 2010Quality of Life and Cost-effectiveness of a 3-Year Trial of Lifestyle Intervention in Primary Health Care110 cited
  • 2010Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving96 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work